270 related articles for article (PubMed ID: 27191608)
1. Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report.
Cai H; Shen H
Braz J Med Biol Res; 2016; 49(6):e5227. PubMed ID: 27191608
[TBL] [Abstract][Full Text] [Related]
2. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
3. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation.
Cakmak H; Katz A; Cedars MI; Rosen MP
Fertil Steril; 2013 Dec; 100(6):1673-80. PubMed ID: 23987516
[TBL] [Abstract][Full Text] [Related]
4. Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.
Simi G; Obino ME; Casarosa E; Litta P; Artini PG; Cela V
Gynecol Endocrinol; 2015; 31(12):966-70. PubMed ID: 26370262
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.
Reichman DE; Davis OK; Zaninovic N; Rosenwaks Z; Goldschlag DE
Fertil Steril; 2012 Nov; 98(5):1225-8. PubMed ID: 22884018
[TBL] [Abstract][Full Text] [Related]
6. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
7. Ovarian response after random-start controlled ovarian stimulation to cryopreserve oocytes in cancer patients.
Campos APC; Geber GP; Hurtado R; Sampaio M; Geber S
JBRA Assist Reprod; 2018 Nov; 22(4):352-354. PubMed ID: 30264947
[TBL] [Abstract][Full Text] [Related]
8. Successful controlled ovarian stimulation and vitrification of oocytes in an adolescent diagnosed with myelodysplastic/pre-malignant clone with monosomy 7.
Peddie VL; Maheshwari A
Hum Fertil (Camb); 2018 Apr; 21(1):39-44. PubMed ID: 28683583
[TBL] [Abstract][Full Text] [Related]
9. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
10. Ovarian stimulation in the luteal phase: systematic review and meta-analysis.
Boots CE; Meister M; Cooper AR; Hardi A; Jungheim ES
J Assist Reprod Genet; 2016 Aug; 33(8):971-80. PubMed ID: 27146151
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation treatment for young women with autoimmune diseases facing treatment with gonadotoxic agents.
Elizur SE; Chian RC; Pineau CA; Son WY; Holzer HE; Huang JY; Gidoni Y; Levin D; Demirtas E; Tan SL
Rheumatology (Oxford); 2008 Oct; 47(10):1506-9. PubMed ID: 18660508
[TBL] [Abstract][Full Text] [Related]
13. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K
Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255
[TBL] [Abstract][Full Text] [Related]
14. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
15. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
16. The effect of aromatase inhibitor on controlled ovarian stimulation for oocyte cryopreservation in adolescent and young cancer patients.
Suzuki R; Horage-Okutsu Y; Kawahara T; Nakamura K; Shiraishi E; Iwahata H; Suzuki-Takahashi Y; Sugishita Y; Takae S; Suzuki N
J Obstet Gynaecol Res; 2023 Mar; 49(3):973-979. PubMed ID: 36606606
[TBL] [Abstract][Full Text] [Related]
17. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
18. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
19. DuoStim: a new option for fertility preservation for a woman with Turner syndrome.
Ito A; Katagiri Y; Tamaki Y; Fukuda Y; Oji A; Morita M
Gynecol Endocrinol; 2020 Dec; 36(12):1144-1148. PubMed ID: 32945708
[TBL] [Abstract][Full Text] [Related]
20. Fertility Preservation Through Oocyte Cryopreservation in a Patient with Ovarian Dysgerminocarcinoma: A Case Report.
Brezina PR; Ding J; Ke RW; Klosky JL; Tillmanns TD
J Reprod Med; 2015; 60(9-10):441-4. PubMed ID: 26592073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]